@article{fdi:010085919,
  title = {{D}olutegravir versus efavirenz-400 as first-line {ART} in {C}ameroon : week 192 data of {NAMSAL} trial},
  author = {{M}poudi-{E}tame, {M}. and {S}anchez, {T}. {T}. and {B}assega, {P}. {O}. and {O}linga, {J}. and {P}elloquin, {R}aphael and {F}oalem, {M}. and {N}jonkep, {C}. and {M}imbe, {E}. and {V}arloteaux, {M}. and {T}ongo, {M}. and {L}amare, {N}. and {P}eeters, {M}artine and {R}eynes, {J}. and {D}elaporte, {E}. and {K}oulla-{S}hiro, {S}. and {K}ouanfack, {C}. and {NAMSAL} {ANRS} {S}tudy {G}roup},
  editor = {},
  language = {{ENG}},
  abstract = {},
  keywords = {{CAMEROUN}},
  booktitle = {},
  journal = {{J}ournal of the {I}nternational {AIDS} {S}ociety},
  volume = {25},
  numero = {suppl. 3},
  pages = {15},
  year = {2022},
  URL = {https://www.documentation.ird.fr/hor/fdi:010085919},
}